Inflammation Clinical Trial
— TriMix17-18Official title:
Biokemiska förändringar Vid förhöjt Partialtryck för Syrgas
NCT number | NCT03190252 |
Other study ID # | EPN 292-17 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 12, 2017 |
Est. completion date | January 30, 2019 |
Verified date | March 2019 |
Source | Sahlgrenska University Hospital, Sweden |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Research hypothesis
- Diving to depths up to 90msw with an oxygen partial pressure of 130kPa in the breathing
gas will affect the central nervous system.
- Diving to depths up to 90msw with an oxygen partial pressure of 130kPa in the breathing
gas will induce inflammatory changes.
Objectives:
- To investigate the presence of cerebrospinal biochemical markers in blood after diving
to depths up to 90msw with an oxygen partial pressure of 130kPa in the breathing gas.
- To investigate the presence of inflammatory markers in blood after diving to depths up
to 90msw with an oxygen partial pressure of 130kPa in the breathing gas.
- To investigate the presence of venous gas emboli (VGE) in blood after diving to depths
up to 90msw with an oxygen partial pressure of 130kPa in the breathing gas.
Status | Completed |
Enrollment | 10 |
Est. completion date | January 30, 2019 |
Est. primary completion date | January 30, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Military diver or individual approved by the Swedish navy to dive or perform work in hyperbaric environments Exclusion Criteria: - As this is a highly selected population there is no exclusion criteria |
Country | Name | City | State |
---|---|---|---|
Sweden | Gothenburg University | Gothenburg |
Lead Sponsor | Collaborator |
---|---|
Sahlgrenska University Hospital, Sweden | Göteborg University, KTH Royal Institute of Technology, Swedish Armed Forces Diving and Naval Medicine Centre |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Concentration of cerebrospinal and inflammatory biochemical markers in blood | E.g. GFAP, Tau, NfL, JCHL-1, VCAM-1, ICAM-1 | Three months | |
Secondary | Presence of Venous Gas Emboli (VGE) | Kisman-Masurel grading | Five days | |
Secondary | Decompression Sickness (DCS) | Clinical diagnosis | Five days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Completed |
NCT03318731 -
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
|
N/A | |
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT06422494 -
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II
|
N/A |